The off-patent medicines industry provides 70% of medicines dispensed to patients in Europe covering over 80% of therapy areas. Generic, biosimilar and value added medicines make treatment options affordable, accessible, and available, so that patients can best manage their disease. These medicines also played a pivotal role during the covid outbreak, where between 70% and 90% of ICU medicines were off patent.